Showing results (1341-1350 of 1,920) with videos related to

Sort By:
Pageof 192
RMD Open|July 5, 2025
Differences in nailfold capillaroscopy findings between limited and diffuse cutaneous systemic sclerosis: a detailed analysisAna Margarida Correia, Rosanna Campitiello, Carmen Pizzorni, et al.
RMD Open|August 19, 2025
Histological synovitis and radiographic damage in knee osteoarthritis: insights from a comprehensive analysis of ultrasound-guided synovial biopsies in 161 patientsPietro Rubortone, Enrico De Lorenzis, Flavia Leone, et al.
RMD Open|June 11, 2025
Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 casesEl-Baraa Adjailia, Hanna Grasshoff, Susanne Schinke, et al.
RMD Open|June 19, 2025
Early effects of ozoralizumab 30 mg in patients with rheumatoid arthritis and inadequate response to methotrexate: a post hoc trajectory analysis of the phase II/III OHZORA trialYusuke Miyazaki, Nobuko Horiuchi, Shunsuke Okamoto, et al.
RMD Open|February 22, 2024
Association between sinusitis and incident rheumatic diseases: a population-based studyVanessa L Kronzer, John M Davis, Andrew C Hanson, et al.
RMD Open|February 27, 2024
Association between disease-modifying antirheumatic drugs for rheumatoid arthritis and risk of incident dementia: a systematic review with meta-analysisWenhui Xie, Yue Hou, Shiyu Xiao, et al.
RMD Open|March 1, 2024
Altered dynamic functional network connectivity in rheumatoid arthritis associated with peripheral inflammation and neuropsychiatric disordersYanmin Zheng, Zhiduo Hou, Shuhua Ma, et al.
RMD Open|March 1, 2024
Re-evaluating the mythical divide between traditional and novel cardiovascular risk factors in rheumatoid arthritisEirik Ikdahl, Mats Julius Stensrud
RMD Open|March 1, 2024
Prospective study of complications and sequelae of glucocorticoid therapy in ANCA-associated vasculitisPaul J Scherbacher, Bernhard Hellmich, You-Shan Feng, et al.
RMD Open|February 15, 2024
Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registryJasmin B Kuemmerle-Deschner, Tilmann Kallinich, Joerg Henes, et al.
Pageof 192